checkAd

     261  0 Kommentare CureVac to Report Fourth Quarter and Full-Year 2023 Financial Results and Business Update on April 24, 2024 - Seite 3

    For further information, please reference the company's reports and documents filed with the U.S. Securities and Exchange Commission (SEC). You may get these documents by visiting EDGAR on the SEC website at www.sec.gov.

    Lesen Sie auch

    SOURCE: CureVac



    View the original press release on accesswire.com


    The CureVac Stock at the time of publication of the news with a fall of -0,58 % to 2,40EUR on Tradegate stock exchange (18. April 2024, 13:26 Uhr).

    Accesswire
    0 Follower
    Autor folgen
    Mehr anzeigen
    We’re a newswire service standout and fast becoming an industry disruptor. We provide regional, national and global news to thousands of clients around the world. We’re also leading the way in social engagement, targeting and analytics.
    Mehr anzeigen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von Accesswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    CureVac to Report Fourth Quarter and Full-Year 2023 Financial Results and Business Update on April 24, 2024 - Seite 3 TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / April 18, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), will report …

    Artikel zu den Werten

    Auch bei Lesern beliebt

    Schreibe Deinen Kommentar

    Disclaimer